Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 East Walnut Street
Long Beach, NY 11561Phone+1 516-889-7447
Summary
- His major research interest is myeloproliferative disease. In his early years, he cultured bone marrow fibroblasts and then conducted cytogenetic studies, which substantiated that bone marrow.fibrosis in primary myelofibrosis is a secondary event due to stem cell defects. Later, he discovered that the IGF-1 receptor assay can help establish polycythemia better than the standard criteria. He
was also the first to publish that MDSC cells increase in MPN and the first to publish that PD-1 and PDL-1 are increased in MPN. Recently, he discovered that TLR-2 is the driving force for inflammatory cytokines and thrombosis in MPN. He has also published extensively about case studies related to lymphoma, myeloma, HTLV-1 lymphoma, and LGL (large granular lymphocytes),
having published a total of 110 peer-reviewed papers.
Education & Training
- One Brooklyn Health System/Brookdale University Hospital and Medical CenterFellowship, Hematology and Medical Oncology, 1972 - 1976
- Icahn School of Medicine at Mount Sinai (NYC Health + Hospitals: Elmhurst)Internship, Transitional Year, 1971 - 1972
- National Taiwan University College of MedicineClass of 1969
Certifications & Licensure
- NY State Medical License 1974 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Primary Gastric Atypical Burkitt Lymphoma: A Rare Case Report.Jing Zheng, Mustafa Wasifuddin, Richard Wu, Akhtar Cheema, Beka Aroshidze
Journal of Investigative Medicine High Impact Case Reports. 2024-11-28 - 1 citationsReview of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer.Mustafa Wasifuddin, Nosakhare Paul Ilerhunmwuwa, Henry Becerra, Narek Hakobyan, Saad Wasifuddin
Journal of Chemotherapy. 2024-11-01 - Racial disparities in the incidence and survival outcomes in diffuse large B-cell lymphoma in adolescents and young adults.Mustafa Wasifuddin, Nosakhare Paul Ilerhunmwuwa, Henry Becerra, Narek Hakobyan, Neharika Shrestha
European Journal of Haematology. 2024-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: